On August 17, 2023, the Critical Path Institute welcomed over 100 life science and community leaders to its new and expanded headquarters in Tucson, Arizona.Continue reading
Category Archives: AZBio News
John Galgiani, MD, director of the Valley Fever Center for Excellence, Honored as an Arizona life science pioneer
John N. Galgiani, MD of the Valley Fever Center for Excellence will be presented with the AZBio Pioneer Award for Lifetime Achievement at the 2023 AZBio Awards on September 27th.
Congratulations Dr. Peay
AZBio team member Dylan N. Peay earned his PhD in Behavioral Neuroscience from Arizona State University. Dr. Peay serves as Manager, Entrepreneurial Programs and Grants on the AZBio team.
Study Links Inherited Mutations to Okur-Chung Neurodevelopment Syndrome
PHOENIX, AZ – August 16, 2023 — Okur-Chung neurodevelopmental syndrome (OCNDS) has long perplexed the medical community with its varied manifestations and genetic origins. A recent study, led by researchers at the Translational Genomics Research Institute (TGen), part of City of Hope, has revealed insights into the hereditary aspects of OCNDS, shedding light on the genetic underpinnings and potential implications for affected families. Continue reading
GT Medical Technologies Awarded the Arizona Bioscience Company of the Year for Disrupting the Status Quo in Brain Tumor Treatment
TEMPE, Ariz., Aug. 15, 2023 /PRNewswire/ — The Arizona Bioindustry Association, Inc. (AZBio) announced that GT Medical Technologies, Inc. (GT MedTech) will be honored as the Arizona Bioscience Company of the Year at the 2023 AZBio Awards and 20th Anniversary Celebration on Sept. 27 in Phoenix, Arizona.Continue reading
Applications Open for 2023 Flinn Seed Grants
The Flinn Foundation Seed Grants to Promote Translational Research Program opened the application for its next cycle of funding on Monday, Aug. 14, 2023. The deadline to apply is Monday, Oct. 2, 2023.Continue reading
C-Path Welcomes Sanofi to its Type 1 Diabetes Consortium to Help Advance Drug Development
The global immunology and diabetes leader will collaborate with C-Path’s T1DC to drive transformative change in type 1 diabetes prevention and treatment.Continue reading
C-Path’s Duchenne Regulatory Science Consortium and Duchenne Data Foundation Announce Collaboration to Advance Solutions for Duchenne Muscular Dystrophy
TUCSON, Ariz. and VEENENDAAL, Netherlands, August 9, 2023 — Critical Path Institute’s (C-Path) Duchenne Regulatory Science Consortium (D-RSC) and the Duchenne Data Foundation (DDF) are excited to announce a joint collaboration aimed at advancing research and improving healthcare for individuals with Duchenne muscular dystrophy (DMD) and other dystrophinopathies (conditions linked to mutations in the DMD gene).Continue reading
Mayo Clinic appoints Victor Ortega, M.D., associate director of Center for Individualized Medicine
PHOENIX, Ariz. — Victor Ortega, M.D., Ph.D., has been named associate director of Mayo
Clinic’s Center for Individualized Medicine in Arizona.Continue reading
Dr. David Alberts: A legacy of encouragement, innovation and scientific rigor
Dr. Alberts, who passed away on July 29 at the age of 83, not only assisted in creating the Arizona Cancer Center in 1976, but he also developed the center’s Cancer Prevention and Control Program into one of the top programs in the United States. He was honored with the inaugural AZBio Pioneer Award in 2012.